Darunavir/cobicistat

Darunavir/cobicistat
Combination of
Darunavir HIV protease inhibitor
Cobicistat Cytochrome P450 (CYP3A) inhibitor
Clinical data
Trade names Prezcobix

Darunavir/cobicistat (trade name Prezcobix) is an antiretroviral medication used to treat and prevent HIV/AIDS. It is a fixed dose combination drug containing 800 mg of darunavir and 150 mg of cobicistat.[1] Darunavir is an HIV protease inhibitor and cobicistat increases the effectiveness of darunavir by blocking its metabolism by the enzyme CYP3A.

It was approved by the Food and Drug Administration for use in United States in 2105.[2]

References

  1. ↑ "Darunavir / Cobicistat". AIDSinfo. U.S. Department of Health and Human Services.
  2. ↑ "Darunavir/Cobicistat (Prezcobix) Combo Pill Clears FDA". Medscape. January 30, 2015.


This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.